Lifeloc Unveils SpinDetect(TM) Centrifugal Drug Analyzer at First Customer Demonstrations
Lifeloc Technologies (OTCID:LCTC) has unveiled its innovative SpinDetect鈩� Centrifugal Drug Analyzer at the International Association of Chiefs of Police Conference in Chicago. The system processes oral fluid samples in under 15 minutes, delivering lab-grade analytical chemistry on a compact, automated disk platform.
The analyzer, based on licensed SpinDx鈩� microfluidic technology from Sandia Corporation, can detect multiple substances including delta-9-THC at 10 ng/ml, cocaine, fentanyl, amphetamine, methamphetamine, morphine, MDMA, and benzodiazepines. The company plans a phased commercial launch starting in 2026, initially focusing on THC detection disks, followed by expanded drug panels and additional sample types from blood and breath.
Lifeloc Technologies (OTCID:LCTC) ha presentato il suo innovativo SpinDetect鈩� Centrifugal Drug Analyzer alla conferenza dell'International Association of Chiefs of Police a Chicago. Il sistema analizza campioni di fluido orale in meno di 15 minuti, offrendo analisi chimiche di qualit脿 laboratoristica su una piattaforma compatta e automatizzata a disco.
L'analizzatore, basato sulla tecnologia microfluidica SpinDx鈩� concessa in licenza dalla Sandia Corporation, 猫 in grado di rilevare pi霉 sostanze tra cui delta-9-THC a 10 ng/ml, cocaina, fentanil, anfetamina, metamfetamina, morfina, MDMA e benzodiazepine. L'azienda prevede un lancio commerciale graduale a partire dal 2026, concentrandosi inizialmente sui dischi per il rilevamento del THC, per poi ampliare i pannelli di rilevamento e includere altri tipi di campioni come sangue e respiro.
Lifeloc Technologies (OTCID:LCTC) present贸 su innovador SpinDetect鈩� Centrifugal Drug Analyzer en la conferencia de la International Association of Chiefs of Police en Chicago. El sistema procesa muestras de fluido oral en menos de 15 minutos, ofreciendo qu铆mica anal铆tica de nivel de laboratorio en una plataforma compacta y automatizada de disco.
El analizador, basado en la tecnolog铆a microflu铆dica SpinDx鈩� licenciada por Sandia Corporation, puede detectar m煤ltiples sustancias, incluido el delta-9-THC a 10 ng/ml, coca铆na, fentanilo, anfetamina, metanfetamina, morfina, MDMA y benzodiazepinas. La compa帽铆a planea un lanzamiento comercial por fases a partir de 2026, enfoc谩ndose inicialmente en discos para detectar THC y luego ampliando los paneles de drogas y los tipos de muestras a sangre y aliento.
Lifeloc Technologies (OTCID:LCTC)電� 鞁滌勾瓿犾棎靹� 鞐措Π 甑牅 瓴届鞍靹滌灔 順戫殞(International Association of Chiefs of Police) 須岇潣鞐愳劀 順侅嫚鞝侅澑 SpinDetect鈩� Centrifugal Drug Analyzer毳� 瓿店皽頄堨姷雼堧嫟. 鞚� 鞁滌姢韰滌潃 韮�鞎� 靸橅攲鞚� 15攵� 鞚措偞鞐� 觳橂Μ頃橂┌, 靻岉槙 鞛愲彊 霐旍姢韥� 頂岆灚韽检棎靹� 鞁ろ棙鞁� 靾橃鞚� 攵勳劃 頇旐暀鞚� 鞝滉车頃╇媹雼�.
Sandia Corporation鞙茧攵�韯� 霛检澊靹犾姢 氚涭潃 SpinDx鈩� 毵堨澊韥頂岆（鞚措敃 旮办垹鞚� 旮半皹鞙茧 頃� 鞚� 攵勳劃旮半姅 delta-9-THC 10 ng/ml毳� 韽暔頃� 旖旍勾鞚�, 韼滍儉雼�, 鞎旐帢韮�氙�, 氅旍姢鞎旐帢韮�氙�, 氇ゴ頃�, MDMA, 氩れ“霐旍晞鞝滍晙 霌� 鞐煬 氍检鞚� 瓴�於滍暊 靾� 鞛堨姷雼堧嫟. 須岇偓電� 2026雲勲秬韯� 雼硠鞝� 靸侅梾 於滌嫓毳� 瓿勴殟頃橁碃 鞛堨溂氅�, 齑堦赴鞐� THC 瓴�於滌毄 霐旍姢韥棎 欤茧牓頃� 霋� 鞎诫 韺剱瓿� 順堨暋 氚� 順疙潯 霌� 於旉皜 靸橅攲 鞙犿槙鞙茧 頇曤寑頃� 鞓堨爼鞛呺媹雼�.
Lifeloc Technologies (OTCID:LCTC) a d茅voil茅 son innovant SpinDetect鈩� Centrifugal Drug Analyzer lors de la conf茅rence de l'International Association of Chiefs of Police 脿 Chicago. Le syst猫me traite des 茅chantillons de salive en moins de 15 minutes, offrant une chimie analytique de qualit茅 laboratoire sur une plateforme compacte et automatis茅e 脿 disque.
L'analyseur, bas茅 sur la technologie microfluidique SpinDx鈩� sous licence de Sandia Corporation, peut d茅tecter plusieurs substances dont le delta-9-THC 脿 10 ng/ml, la coca茂ne, le fentanyl, les amph茅tamines, la m茅thamph茅tamine, la morphine, le MDMA et les benzodiaz茅pines. La soci茅t茅 pr茅voit un lancement commercial progressif 脿 partir de 2026, en se concentrant d'abord sur les disques de d茅tection du THC, puis en 茅largissant les panels de d茅pistage et les types d'茅chantillons aux pr茅l猫vements sanguins et 脿 l'haleine.
Lifeloc Technologies (OTCID:LCTC) hat auf der Konferenz der International Association of Chiefs of Police in Chicago seinen innovativen SpinDetect鈩� Centrifugal Drug Analyzer vorgestellt. Das System verarbeitet orale Fl眉ssigkeitsproben in unter 15 Minuten und liefert labor眉bliche analytische Chemie auf einer kompakten, automatisierten Scheibenplattform.
Der Analysator, der auf der lizenzierten SpinDx鈩�-Mikrofluidiktechnologie der Sandia Corporation basiert, kann mehrere Substanzen nachweisen, darunter delta-9-THC bei 10 ng/ml, Kokain, Fentanyl, Amphetamin, Methamphetamin, Morphin, MDMA und Benzodiazepine. Das Unternehmen plant eine gestaffelte Markteinf眉hrung ab 2026, zun盲chst mit Fokus auf THC-Nachweisscheiben und anschlie脽end auf erweiterte Drogentests sowie weitere Probenarten wie Blut und Atem.
- None.
- Commercial launch not expected until 2026
- Additional financing may be required to complete development
- Currently limited to oral fluid testing only
WHEAT RIDGE, CO / / August 25, 2025 / Lifeloc Technologies, Inc. (OTCID:LCTC), a U.S. leader in portable alcohol and drug testing solutions, unveiled its new SpinDetect鈩� Centrifugal Drug Analyzer during live demonstrations at the International Association of Chiefs of Police Impaired Driving and Traffic Safety Conference held in Chicago, August 4-6, 2025.
The SpinDetect鈩� system brings lab-grade analytical chemistry onto a compact, automated disk platform that can be run with minimal user interaction. At the conference, law enforcement officials and toxicologists saw firsthand how the system processes oral fluid samples with results displayed in under 15 minutes.
Dr. Curtis Stumpf, Senior Scientist at Lifeloc, led the demonstrations. "It is exciting to showcase how far we've taken this technology-from benchtop chemistry to a streamlined system that runs automatically once the sample is added," said Dr. Stumpf.
Lifeloc has named the new product the SpinDetect鈩� Centrifugal Drug Analyzer, reflecting its foundation in the licensed SpinDx鈩� microfluidic technology from Sandia Corporation. The prototype kit, demonstration in progress, and prototype disk design are shown in the following photographs.
"Our prototype looks like a miniature chemical plant on a disk," said Dr. Wayne Willkomm, President and CEO of Lifeloc. "There's a section for mixing, a section for reaction, and a section for separation and measurement-all working together to indicate the presence of targeted drugs. It is a truly compact, self-contained analytical system."
Key Product Features
Validated Capability: SpinDetect鈩� Centrifugal Drug Analyzer has been tested in Lifeloc's laboratory against definitive LCMS methods using human saliva samples, detecting substances including delta-9-THC at approximately 10 ng/ml, as well as cocaine, fentanyl, amphetamine, methamphetamine, morphine, MDMA, and benzodiazepines.
Automated Workflow: Once the sample is introduced, the pre-loaded, shelf-stable test disk performs the analysis without user intervention.
Platform Potential: The modular design supports single-analyte tests (such as THC) as well as expanded drug panels under development as well as analysis of samples beyond oral fluid.
We are also beginning beta testing of our SpinDetectTM Centrifugal Drug Analyzer oral fluid testing system utilizing the delta-9-THC only. An agreement for beta testing is in place, and the test logistics are being finalized. The initial product release is projected to be a device with a disk that allows for detection of delta-9-THC (the major intoxicating component of the cannabis plant) from a test subject's oral fluid, followed by a disk for a panel of other drugs. Commercial launch of our first SpinDetectTM Centrifugal Drug Analyzer application is projected to occur in 2026. Lifeloc is preparing for a phased rollout of the SpinDetect鈩� system, beginning with THC detection disks, followed by additional drug panels and samples collected from blood and breath. Following the release of our SpinDetectTM Centrifugal Drug Analyzer oral fluid testing system, we expect to accelerate development of combining our LX9 breathalyzer with the THC SpinDetectTM Centrifugal Drug Analyzer, to produce our roadside marijuana breathalyzer system. The current pace of development may require additional financing to complete.
About Lifeloc Technologies
Lifeloc Technologies, Inc. (OTCID: LCTC) is a trusted U.S. manufacturer of evidential breath alcohol testers and related training and supplies for Workplace, Law Enforcement, Corrections and International customers. Lifeloc stock trades over-the-counter under the symbol LCTC. We are a fully reporting Company with our SEC filings available on our web site, .
Forward Looking Statements
This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which involve substantial risks and uncertainties that may cause actual results to differ materially from those indicated by the forward-looking statements. All forward-looking statements expressed or implied in this press release, including statements about our strategies, performance, expectations about new and existing products, market demand, economic conditions, acceptance of new and existing products, technologies and opportunities, market size and growth, market liquidity for our shares, and return on investments in products and market, are based on information available to us on the date of this document, and we assume no obligation to update such forward-looking statements. Investors are strongly encouraged to review the section titled "Risk Factors" in our .
SpinDetectTM is a trademark of Lifeloc Technologies, Inc.
SpinDx鈩� is a trademark of Sandia Corporation.
Amy Evans
Lifeloc Technologies, Inc.
(303) 431-9500
SOURCE: Lifeloc Technologies, Inc.
View the original on ACCESS Newswire
FAQ
What is Lifeloc's SpinDetect鈩� Centrifugal Drug Analyzer and how does it work?
When will Lifeloc (LCTC) launch the SpinDetect鈩� drug analyzer commercially?
What drugs can the Lifeloc SpinDetect鈩� system detect?
What are the key features of Lifeloc's SpinDetect鈩� drug testing system?
What is the current development status of Lifeloc's SpinDetect鈩� analyzer?
